Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
boston blog main
3
×
deals
3
×
life sciences
national blog main
san francisco blog main
3
×
boston top stories
clinical trials
fda
investing
new york blog main
startups
vc
akouos
arrowmark partners
astellas pharmaceuticals
azacitidine
beta bionics
beta-thalassemia
bigfoot biomedical
boston university
california institute for biomedical research
congenital hyperinsulinism
dacogen
decibel therapeutics
decitabine
dexcom
diabetes
dna
drug delivery
edward damiano
eli lilly
epigenetics
epizyme
eventide asset management
farydak
flagship pioneering
frequency therapeutics
fulcrum therapeutics
What
developing
3
×
medicines
startup
therapeutics
affects
aims
americans
approach
approved
based
beta
bionics
biotech
blood
called
closed
date
debuts
device
diabetes
driven
drug
drugs
epigenetic
epigenetics
fda
field
flagship’s
frequency
heads
hearing
ipo
key
levels
loss
manages
medical
meds
million
millions
Language
unset
Current search:
deals
×
developing
×
" boston blog main "
×
" san francisco blog main "
×
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests